BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 2071165)

  • 21. Characterization of a peptide analog of a determinant of type II collagen that suppresses collagen-induced arthritis.
    Myers LK; Tang B; Rosloniec EF; Stuart JM; Chiang TM; Kang AH
    J Immunol; 1998 Oct; 161(7):3589-95. PubMed ID: 9759881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo elimination of T cells expressing specific T-cell receptor V beta chains in mice susceptible to collagen-induced arthritis.
    Goldschmidt TJ; Jansson L; Holmdahl R
    Immunology; 1990 Apr; 69(4):508-14. PubMed ID: 2139866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance to collagen-induced arthritis in Biozzi mice is not associated with T cell receptor V beta gene polymorphism.
    Vidard L; Roger T; Bouvet JP; Couderc J; Seman M
    Eur J Immunol; 1991 Jul; 21(7):1783-5. PubMed ID: 2060585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restricted TCR V alpha repertoire in the T cell response to a tolerogenic determinant of type II collagen.
    Kawamura S; Miyahara H; Esaki Y; Myers LK; Rosloniec EF; Stuart JM; Kang AH
    J Immunol; 1997 Jun; 158(12):6013-8. PubMed ID: 9190956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD28-deficient mice are highly resistant to collagen-induced arthritis.
    Tada Y; Nagasawa K; Ho A; Morito F; Ushiyama O; Suzuki N; Ohta H; Mak TW
    J Immunol; 1999 Jan; 162(1):203-8. PubMed ID: 9886387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for preferential T cell receptor V beta gene usage and T cell clonal expansion in the synovium of BB rats with early-onset collagen-induced arthritis.
    Ye XJ; Aelion J; Endres RO; Kang AH; Cremer MA
    Cell Immunol; 1998 Feb; 183(2):81-9. PubMed ID: 9606991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cell regulation of collagen-induced arthritis in mice. II. Immunomodulation of arthritis by cytotoxic T cell hybridomas specific for type II collagen.
    Chiocchia G; Boissier MC; Manoury B; Fournier C
    Eur J Immunol; 1993 Feb; 23(2):327-32. PubMed ID: 8436167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of MHC class II and TCR binding residues in the type II collagen immunodominant determinant mediating collagen-induced arthritis.
    Rosloniec EF; Whittington KB; Brand DD; Myers LK; Stuart JM
    Cell Immunol; 1996 Aug; 172(1):21-8. PubMed ID: 8806802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci.
    Watson WC; Townes AS
    J Exp Med; 1985 Dec; 162(6):1878-91. PubMed ID: 3934318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
    Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
    Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of C5 and T-cell receptor Vb genes in susceptibility to collagen-induced arthritis.
    Spinella DG; Jeffers JR; Reife RA; Stuart JM
    Immunogenetics; 1991; 34(1):23-7. PubMed ID: 1855815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T cell receptors recognizing type II collagen in HLA-DR-transgenic mice characterized by highly restricted V beta usage.
    He X; Rosloniec EF; Myers LK; McColgan WL; Gumanovskaya M; Kang AH; Stuart JM
    Arthritis Rheum; 2004 Jun; 50(6):1996-2004. PubMed ID: 15188377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structures on the I-A molecule predisposing for susceptibility to type II collagen-induced autoimmune arthritis.
    Gustafsson K; Karlsson M; Andersson L; Holmdahl R
    Eur J Immunol; 1990 Sep; 20(9):2127-31. PubMed ID: 2209706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenetics of type II collagen autoimmunity and susceptibility to collagen arthritis.
    Holmdahl R; Jansson L; Andersson M; Larsson E
    Immunology; 1988 Oct; 65(2):305-10. PubMed ID: 3192274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
    Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the T cell determinants in the induction of autoimmune arthritis by bovine alpha 1(II)-CB11 in H-2q mice.
    Brand DD; Myers LK; Terato K; Whittington KB; Stuart JM; Kang AH; Rosloniec EF
    J Immunol; 1994 Mar; 152(6):3088-97. PubMed ID: 7511638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-cell receptor vbeta deletion and valpha polymorphism are responsible for the resistance of SWR mouse to arthritis induction.
    Osman GE; Hannibal MC; Anderson JP; Cheunsuk S; Lasky SR; Liggitt HD; Ladiges WC; Hood LE
    Immunogenetics; 1999 Aug; 49(9):764-72. PubMed ID: 10398803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential activities of immunogenic collagen type II peptides in the induction of nasal tolerance to collagen-induced arthritis.
    Chu CQ; Londei M
    J Autoimmun; 1999 Feb; 12(1):35-42. PubMed ID: 10028020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycosylation of type II collagen is of major importance for T cell tolerance and pathology in collagen-induced arthritis.
    Bäcklund J; Treschow A; Bockermann R; Holm B; Holm L; Issazadeh-Navikas S; Kihlberg J; Holmdahl R
    Eur J Immunol; 2002 Dec; 32(12):3776-84. PubMed ID: 12516572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Origin of the autoreactive anti-type II collagen response. II. Specificities, antibody isotypes and usage of V gene families of anti-type II collagen B cells.
    Holmdahl R; Bailey C; Enander I; Mayer R; Klareskog L; Moran T; Bona C
    J Immunol; 1989 Mar; 142(6):1881-6. PubMed ID: 2493500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.